Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study
While functional loss forms part of the current diagnostic criteria used to identify dementia due to Alzheimer's disease, the gradual and progressive nature of the disease makes it difficult to recognize clinically relevant signposts that could be helpful in making treatment and management deci...
Saved in:
Published in | The journal of prevention of Alzheimer's disease Vol. 4; no. 2; p. 72 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
France
2017
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | While functional loss forms part of the current diagnostic criteria used to identify dementia due to Alzheimer's disease, the gradual and progressive nature of the disease makes it difficult to recognize clinically relevant signposts that could be helpful in making treatment and management decisions. Having previously observed a significant relationship between stages of functional dependence (the level of assistance patients require consequent to Alzheimer's disease deficits, derived from the Alzheimer's Disease Cooperative Study - Activities of Daily Living Scale) and cognitive severity, we investigated whether measures of functional dependence could be utilized to identify clinical milestones of Alzheimer's disease progression.
To describe the patterns of change in dependence over the course of 18 months in groups stratified according to cognitive Alzheimer's disease dementia severity (determined using the Mini-Mental State Examination score) and to identify characteristics associated with patients showing worsening dependence (progressors) versus those showing no change or improvement (non-progressors).
Analysis of longitudinal data from the GERAS study.
GERAS is an 18-month prospective, multicenter, naturalistic, observational cohort study reflecting the routine care of patients with Alzheimer's disease in France, Germany, and the United Kingdom.
1495 community-living patients, aged ≥55 years, diagnosed with probable Alzheimer's disease dementia, and their caregivers.
Dependence levels, cognitive function, behavioral symptoms, caregiver burden, and cost were assessed at baseline and at 18 months.
Of 971 patients having both baseline and 18-month data, 42% (408) were progressors and 563 (58%) were non-progressors. This general pattern held for all three levels of baseline Alzheimer's disease dementia severity - mild (Mini-Mental State Examination score 21-26), moderate (15-20) or moderately severe/severe (<15) - with 40-45% of each group identified as progressors and 55-60% as non-progressors. No baseline differences were seen between progressors and non-progressors in cognitive scores or behavioral symptoms, although progressors had significantly shorter times since diagnosis and showed milder functional impairment. Baseline factors predictive of increasing dependence over 18 months included more severe cognitive impairment, living with others, and having multiple caregivers. A higher level of initial dependence was associated with less risk of dependence progression. Total societal costs of care also increased with greater dependence.
In this large cohort, 42% of Alzheimer's disease dementia patients at all levels of cognitive severity became more dependent within 18 months of observation while 58% did not progress. Dependence levels may be considered as meaningful interim clinical milestones that reflect Alzheimer's disease-related functional deficits, although a time frame that extends beyond 18 months may be necessary to observe changes if used in clinical trials or other longitudinal studies. Recognition of predictors of greater dependence offers opportunities for intervention. |
---|---|
AbstractList | While functional loss forms part of the current diagnostic criteria used to identify dementia due to Alzheimer's disease, the gradual and progressive nature of the disease makes it difficult to recognize clinically relevant signposts that could be helpful in making treatment and management decisions. Having previously observed a significant relationship between stages of functional dependence (the level of assistance patients require consequent to Alzheimer's disease deficits, derived from the Alzheimer's Disease Cooperative Study - Activities of Daily Living Scale) and cognitive severity, we investigated whether measures of functional dependence could be utilized to identify clinical milestones of Alzheimer's disease progression.
To describe the patterns of change in dependence over the course of 18 months in groups stratified according to cognitive Alzheimer's disease dementia severity (determined using the Mini-Mental State Examination score) and to identify characteristics associated with patients showing worsening dependence (progressors) versus those showing no change or improvement (non-progressors).
Analysis of longitudinal data from the GERAS study.
GERAS is an 18-month prospective, multicenter, naturalistic, observational cohort study reflecting the routine care of patients with Alzheimer's disease in France, Germany, and the United Kingdom.
1495 community-living patients, aged ≥55 years, diagnosed with probable Alzheimer's disease dementia, and their caregivers.
Dependence levels, cognitive function, behavioral symptoms, caregiver burden, and cost were assessed at baseline and at 18 months.
Of 971 patients having both baseline and 18-month data, 42% (408) were progressors and 563 (58%) were non-progressors. This general pattern held for all three levels of baseline Alzheimer's disease dementia severity - mild (Mini-Mental State Examination score 21-26), moderate (15-20) or moderately severe/severe (<15) - with 40-45% of each group identified as progressors and 55-60% as non-progressors. No baseline differences were seen between progressors and non-progressors in cognitive scores or behavioral symptoms, although progressors had significantly shorter times since diagnosis and showed milder functional impairment. Baseline factors predictive of increasing dependence over 18 months included more severe cognitive impairment, living with others, and having multiple caregivers. A higher level of initial dependence was associated with less risk of dependence progression. Total societal costs of care also increased with greater dependence.
In this large cohort, 42% of Alzheimer's disease dementia patients at all levels of cognitive severity became more dependent within 18 months of observation while 58% did not progress. Dependence levels may be considered as meaningful interim clinical milestones that reflect Alzheimer's disease-related functional deficits, although a time frame that extends beyond 18 months may be necessary to observe changes if used in clinical trials or other longitudinal studies. Recognition of predictors of greater dependence offers opportunities for intervention. |
Author | Gauthier, S Kahle-Wrobleski, K Ye, W Galasko, D Rentz, D M Andrews, J S Belger, M |
Author_xml | – sequence: 1 givenname: K surname: Kahle-Wrobleski fullname: Kahle-Wrobleski, K email: wrobleski_kristin_kahle@lilly.com organization: Kristin Kahle-Wrobleski, PhD, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN 46285, USA, Phone: 317-651-9881, Fax: 317-276-5791, Email: wrobleski_kristin_kahle@lilly.com – sequence: 2 givenname: J S surname: Andrews fullname: Andrews, J S – sequence: 3 givenname: M surname: Belger fullname: Belger, M – sequence: 4 givenname: W surname: Ye fullname: Ye, W – sequence: 5 givenname: S surname: Gauthier fullname: Gauthier, S – sequence: 6 givenname: D M surname: Rentz fullname: Rentz, D M – sequence: 7 givenname: D surname: Galasko fullname: Galasko, D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29186278$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kM1uwjAQhK2qVaGUW8-Vbz2FOo6xnd5QoBQJhATtGZl4XYwSJ4odJHiKPnKj_pxG-nZ2Rzt36NpVDhB6iMkoZlQmz8da6RElsRjRK9SnjPKIUM57aOj9kRASpzFPUnmLejSNJadC9tHXFGpwGlwOeAknKDxWHi9cgMaWOCuss7kq8MoW4EOX5_GkqNwnDgfAWeWCdW1b4sp0-HIAW0Lz5PHUelAeXnAso1VnOuAN-LYIHpumKn9257PNZIvXew_NSQVbuS5kG1p9vkc3RhUehn86QB-vs_fsLVqu54tssozyRLIQiSQfMy6YVNwIwRRPjcg5SWhiOJMipUBSYrop5VpqnlLGNJix7pjgDAwdoMffu3W7L0Hv6u5f1Zx3_9XQb51NZtc |
CitedBy_id | crossref_primary_10_1002_alz_12874 crossref_primary_10_1111_hsc_13745 crossref_primary_10_3892_etm_2022_11166 crossref_primary_10_1002_mgg3_1548 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.14283/jpad.2017.2 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 2426-0266 |
ExternalDocumentID | 29186278 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: P50 AG005131 |
GroupedDBID | -EM 406 AACDK AAHNG AAJBT AASML AATNV AAUYE ABAKF ABDZT ABECU ABFTV ABKCH ABMQK ABTEG ABTKH ACAOD ACDTI ACHSB ACIPQ ACOKC ACZOJ ADKNI ADURQ ADYFF AEFQL AEMSY AESKC AFQWF AGDGC AGJBK AGMZJ AGQEE AGRTI AIAKS AIGIU AILAN AITGF AJZVZ ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AXYYD BGNMA DPUIP EBLON EBS EJD FIGPU FINBP FNLPD FSGXE GGCAI IKXTQ IWAJR J-C JZLTJ KOV LLZTM M4Y NPM NPVJJ NQJWS NU0 O9J PT4 ROL RSV SJN SJYHP SNE SNPRN SOHCF SOJ SRMVM SSLCW STPWE UOJIU UTJUX VEKWB VFIZW ZMTXR |
ID | FETCH-LOGICAL-c384t-73c546748a6f774a69f7c60323f648792e090f8a626d8d69244def5d0f8764ef2 |
IngestDate | Wed Oct 16 00:59:29 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | ADCS-ADL dependence Alzheimer disease GERAS observational study |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c384t-73c546748a6f774a69f7c60323f648792e090f8a626d8d69244def5d0f8764ef2 |
OpenAccessLink | https://www.jpreventionalzheimer.com/download.html?type=pdf&id=279 |
PMID | 29186278 |
ParticipantIDs | pubmed_primary_29186278 |
PublicationCentury | 2000 |
PublicationDate | 2017-00-00 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – year: 2017 text: 2017-00-00 |
PublicationDecade | 2010 |
PublicationPlace | France |
PublicationPlace_xml | – name: France |
PublicationTitle | The journal of prevention of Alzheimer's disease |
PublicationTitleAlternate | J Prev Alzheimers Dis |
PublicationYear | 2017 |
References | 8056940 - J Gerontol. 1994 Sep;49(5):M216-22 18662215 - J Am Geriatr Soc. 2008 Aug;56(8):1497-503 24450890 - N Engl J Med. 2014 Jan 23;370(4):311-21 9153155 - Neurology. 1997 May;48(5 Suppl 6):S10-6 18840808 - J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):1005-9 23629588 - J Alzheimers Dis. 2013;36(2):385-99 6610841 - Neurology. 1984 Jul;34(7):939-44 23578568 - Prog Neurobiol. 2013 Nov;110:102-13 26170703 - Clinicoecon Outcomes Res. 2015 Jul 02;7:387-95 19187414 - J Am Geriatr Soc. 2009 Mar;57(3):536-46 1202204 - J Psychiatr Res. 1975 Nov;12(3):189-98 10109801 - Health Policy. 1990 Dec;16(3):199-208 21514250 - Alzheimers Dement. 2011 May;7(3):263-9 12164728 - Arch Neurol. 2002 Aug;59(8):1304-8 25125457 - J Alzheimers Dis. 2015;43(3):949-55 25074342 - Alzheimers Dement. 2015 Mar;11(3):280-90 24635843 - Curr Alzheimer Res. 2014 May;11(4):357-66 28775969 - J Prev Alzheimers Dis. 2015 ;2(2):115-120 19262963 - J Nutr Health Aging. 2009 Mar;13(3):256-9 24363071 - Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):738-49 23809364 - Alzheimers Dement. 2013 Jul;9(4):438-44 9236950 - Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9 25754669 - Int J Geriatr Psychiatry. 2015 Dec;30(12):1230-7 21668424 - Acta Psychiatr Scand. 2011 Sep;124(3):165-83 7203086 - Gerontologist. 1980 Dec;20(6):649-55 25846298 - Alzheimers Dement. 2015 Aug;11(8):933-45 |
References_xml | |
SSID | ssj0001916398 |
Score | 2.1383078 |
Snippet | While functional loss forms part of the current diagnostic criteria used to identify dementia due to Alzheimer's disease, the gradual and progressive nature of... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 72 |
Title | Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29186278 |
Volume | 4 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LbxMxEICtFC5cEKi8C_KhEodoy-56Y3t7C6UPgVokaEU5Vfau3QYlaaTdcOiv4C_xzxiPvY-Eh4DLKlpnE8vzrT0z9swQsh1rk_FSZxFXDAwUlbJICZ1ECiRimTSC4-758Qk_Osveno_OB4PvvVNLy1rvFDe_jCv5H6nCPZCri5L9B8m2Pwo34DPIF64gYbj-lYzfhAq2GJbzFVY5VzUGfXyT2XCviXk8hhffqXimGo6n1yE6ymWlmsyXyxmqotObKzPBOiqicgk53Z4N-gpkBC99feW8_MtpXXXRKIf7H8Yfh-9169R1WUXaVLVfOgZ7qSkWIV2UV1FX_3Rto-idq8ocfcJqN6Gydne0AM9gev46z-1rM730-LW-pM-mPUHYODYS0XNsGJwAnfYQgY3I-7N11oMy7c28vgDQTwuCyyfnVoSFcmlhE7Gz8jUYycUM4UjzBGw7X03oz61r6bmbpg2yIaSbYk-CuwidfKB8s1yGgAvXl1e9nrhE1OHpNaMGlZvTe-RusEro2CN2nwzMfJN86_CiHi-qKhrwog1etMOLIl4U8KAtXvTa0lbSLysa4NqlDVo0oEUdWvgsokVX0KKI1gNydrB_uncUhQIeUcFkVkeCFSOsZqO4BTND8dyKgscsZZaDoZynJs5jC60pL2XJc1A1S2NHJdwTPDM2fUhuzaH_jwl1mqnmmZaFjDOhpGSJTawShRZgg0j7hDzyA3ix8FlaLpqhffrblmfkTsfdFrltYVowz0HHrPULlOMP6ap-BQ |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dependence+Levels+as+Interim+Clinical+Milestones+Along+the+Continuum+of+Alzheimer%27s+Disease%3A+18-Month+Results+from+the+GERAS+Observational+Study&rft.jtitle=The+journal+of+prevention+of+Alzheimer%27s+disease&rft.au=Kahle-Wrobleski%2C+K&rft.au=Andrews%2C+J+S&rft.au=Belger%2C+M&rft.au=Ye%2C+W&rft.date=2017-01-01&rft.eissn=2426-0266&rft.volume=4&rft.issue=2&rft.spage=72&rft_id=info:doi/10.14283%2Fjpad.2017.2&rft_id=info%3Apmid%2F29186278&rft_id=info%3Apmid%2F29186278&rft.externalDocID=29186278 |